BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 19878396)

  • 1. Do we have to pay more attention to vitiligo patients? Peculiar histopathological features of primary cutaneous melanoma preceded by vitiligo.
    Onsun N; Büyükbabani N; Ummetoğlu O; Cebeci F
    J Dermatol; 2009 Nov; 36(11):612-5. PubMed ID: 19878396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitiligo: a good prognostic factor in melanoma?
    Cunha D; Pacheco FA; Cardoso J
    Dermatol Online J; 2009 Feb; 15(2):15. PubMed ID: 19336032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma with second myxoid stromal changes after personally applied prolonged phototherapy.
    Ulamec M; Soldo-Belić A; Vucić M; Buljan M; Kruslin B; Tomas D
    Am J Dermatopathol; 2008 Apr; 30(2):185-7. PubMed ID: 18360128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spitzoid melanoma.
    Kamino H
    Clin Dermatol; 2009; 27(6):545-55. PubMed ID: 19880042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
    Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
    J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitiligo-like primary melanoma.
    Lugo-Somolinos A; Sánchez JL; Garcia ME
    Am J Dermatopathol; 2008 Oct; 30(5):451-4. PubMed ID: 18806487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sentinel node biopsy in cutaneous malignant melanoma of the lower extremities].
    Kjaer BK; Knudsen MA; Dahlstrøm KK
    Ugeskr Laeger; 1999 Apr; 161(16):2358-61. PubMed ID: 10235040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki-67 expression in melanoma. A potential method of risk assessment for the patient with a positive sentinel node.
    Pearl RA; Pacifico MD; Richman PI; Stott DJ; Wilson GD; Grobbelaar AO
    J Exp Clin Cancer Res; 2007 Mar; 26(1):109-15. PubMed ID: 17550139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic melanoma and vitiligo: a case report.
    Buljan M; Situm M; Lugović L; Vucić M
    Acta Dermatovenerol Croat; 2006; 14(2):100-3. PubMed ID: 16859616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of malignant melanoma, axillary lymph node metastasis proved by fine needle aspiration biopsy cytology].
    Shinozaki N; Hashimoto K; Yamaguchi A; Hukunaga M; Hosoya T; Uchida K; Ishikawa M; Sakurai K
    Gan No Rinsho; 1987 Apr; 33(4):438-41. PubMed ID: 3573315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic malignant melanoma associated with vitiligo-like depigmentation.
    Wang JR; Yu KJ; Juan WH; Yang CH
    Clin Exp Dermatol; 2009 Mar; 34(2):209-11. PubMed ID: 18691245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model for pretest probability of lymph node metastasis from cutaneous Melanoma.
    Vollmer RT; Seigler HF
    Am J Clin Pathol; 2000 Dec; 114(6):875-9. PubMed ID: 11338476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant melanoma.
    Califano J; Nance M
    Facial Plast Surg Clin North Am; 2009 Aug; 17(3):337-48. PubMed ID: 19698915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimelanoma immunity in vitiligo and melanoma patients.
    Juranic ZD; Stanojevic-Bakic N; Zizak Z; Babovic N; Radovic-Kovacevic V; Stanojkovic T; Dzodic R
    Neoplasma; 2003; 50(4):305-9. PubMed ID: 12937846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmoplastic and neurotropic melanoma.
    Su LD; Fullen DR; Lowe L; Wang TS; Schwartz JL; Cimmino VM; Sondak VK; Johnson TM
    Cancer; 2004 Feb; 100(3):598-604. PubMed ID: 14745878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural course of cutaneous melanoma.
    Leiter U; Meier F; Schittek B; Garbe C
    J Surg Oncol; 2004 Jul; 86(4):172-8. PubMed ID: 15221923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma].
    Eigentler TK; Radny P; Kamin A; Weide B; Caroli UM; Garbe C
    J Dtsch Dermatol Ges; 2005 Aug; 3(8):592-8. PubMed ID: 16033477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse cutaneous melanosis in malignant melanoma.
    Paulo Filho Tde A; da Trindade Neto PB; Reis JC; Bartelt L; da Costa SA
    Dermatol Online J; 2007 May; 13(2):9. PubMed ID: 17498428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.